本页面由Tiger Trade Technology Pte. Ltd.提供服务

Nurix Therapeutics

22.42
+0.26001.17%
成交量:126.91万
成交额:2,845.25万
市值:23.18亿
市盈率:-6.57
高:22.71
开:22.20
低:21.75
收:22.16
52周最高:28.23
52周最低:9.14
股本:1.03亿
流通股本:7,411.19万
量比:1.57
换手率:1.71%
股息:- -
股息率:- -
每股收益(TTM):-3.4102
每股收益(LYR):-3.0514
净资产收益率:-80.30%
总资产收益率:-40.06%
市净率:5.76
市盈率(LYR):-7.35

数据加载中...

2024/04/10

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/04/10

重要事件披露

Form 8-K - Current report
2024/04/09

重要事件披露

Form 8-K - Current report
2024/03/11

重要事件披露

Form 8-K - Current report
2024/02/16

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/02/15

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/02/15

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/02/15

重要事件披露

Form 8-K - Current report
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/02/14

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/01/30

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/01/08

重要事件披露

Form 8-K - Current report
2023/12/20

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/12/12

重要事件披露

Form 8-K - Current report
2023/11/13

重要事件披露

Form 8-K - Current report
2023/11/01

重要事件披露

Form 8-K - Current report
2023/10/13

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]